MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Quality of life assessment in patients with Parkinson’s disease

S. Frikha, O. Ben Othmen, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

Meeting: 2024 International Congress

Abstract Number: 599

Keywords: Parkinson’s

Category: Quality Of Life/Caregiver Burden in Movement Disorders

Objective: The objective of the study was to assess the quality of life in patients with Parkinson’s disease (PD) and to establish statistical correlations with clinical characteristics and especially psychiatric symptoms of PD.

Background: Parkinson’s disease (PD) is recognized for both its motor and non-motor symptoms. Those symptoms may have an impact in patient’s quality of life (QOL), as PD is a chronic and potentially disabling disease.

Method: We conducted a transversal population-based study of patients followed in the department of Neurology of Charles Nicolle hospital of Tunisia for PD.

QOL was assessed by PDQ-39 (Parkinson Disease Quality of life) scale, which includes 39 questions covering 8 domains.

Results: Our study included 30 patients with PD. The average age of our patients was 64.17+-9 years with a sex ratio of 0.66. The PDQ-39 score covered 8 areas: The average score for mobility was=28.70; activities of daily living=29.53; emotional well-being=55.97; psychological discomfort=41; social support=23.17; cognitive disorders=35.77 with; communication=27 and physical discomfort=32. We observed a statistically significant correlation between sleep disorders and daily living activities (p=0.05), as well as emotional well-being (p=0.03). Depression was correlated with emotional well-being (p=0.01) and physical discomfort (p=0.04), as well as for anxiety disorder correlated with emotional well-being (p=0.01) and psychological discomfort (p=0.05).

We did not observe a statistically significant correlation between the quality of life and other psychiatric disorders such as psychotic disorders, sexual disorders, and substance-related disorders.

Conclusion: Assessing the impact of psychiatric disorders on the quality of life of Parkinson’s patients is an important issue. This highlights that clinicians should diagnose these disorders at the onset of the disease and also focus on their management.

To cite this abstract in AMA style:

S. Frikha, O. Ben Othmen, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali. Quality of life assessment in patients with Parkinson’s disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/quality-of-life-assessment-in-patients-with-parkinsons-disease/. Accessed May 10, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/quality-of-life-assessment-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley